ASP2409

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	1

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02171143 (ClinicalTrials.gov)	April 2012	18/6/2014	A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409Following a Si ...	A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Assess the Safety, ...	Rheumatoid Arthritis;Pharmacokinetics of ASP2409	Drug: ASP2409;Drug: Placebo	Astellas Pharma Global Development, Inc.	NULL	Completed	18 Years	75 Years	Both	58	Phase 1	United States

First Previous1Next Last